|
|
||||||||
From the Department of Ophthalmology, Osaka Medical College, Osaka, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. NG-nitro-L-arginine methyl ester (L-NAME) (1, 10, or 100 mg/kg), D-NAME (10 mg/kg), or physiological saline was administered intravenously to albino rabbits. A quantitative index of blood velocity, the normalized blur (NB), was measured in the ONH by laser speckle tissue circulation analyzer. The intraocular pressure (IOP) and blood pressure (BP) were also measured. L-arginine (10 mg/kg) was intravenously administered 20 minutes after L-NAME (10 mg/kg) injection. Acetylcholine (ACh; 10 µg/kg per minute) was infused for 15 minutes, with or without pretreatment of L-NAME (1 mg/kg).
RESULTS. L-NAME induced a continuous decrease of the NB in a dose-dependent manner, but D-NAME caused no significant change. At 100 mg/kg, L-NAME significantly increased the IOP, mean BP, and ocular perfusion pressure, but the other doses caused no significant changes. When L-arginine was administered after L-NAME injection, the NB returned to its initial level and remained there. Pretreatment with L-NAME inhibited the increase of NB induced by ACh.
CONCLUSIONS. These results indicate that nitric oxide regulates basal tissue circulation in the ONH of conscious rabbits and suggest that ACh increases the circulation by promoting nitric oxide synthesis.
| Introduction |
|---|
|
|
|---|
In the present study, we tried to clarify the effect of NO on ONH circulation in conscious rabbits, by using the laser speckle method and intravenous administration of an NOS inhibitor alone or combined with L- or D-arginine or ACh.
| Materials and Methods |
|---|
|
|
|---|
Drugs Used
NG-nitro-L-arginine
methyl ester (L-NAME) and
NG-nitro-D-arginine
methyl ester (D-NAME) were purchased from Sigma
(St. Louis, MO). L- or
D-arginine and ACh were purchased from Wako
(Osaka, Japan). Each was dissolved in physiological saline (Otsuka,
Tokyo, Japan).
Measurement of ONH Blood Velocity, IOP, and Blood Pressure
The blood velocity in the ONH was measured with a laser speckle
tissue circulation analyzer. The details of this apparatus were
previously reported by Tamaki et al.11
Scattered laser
light is projected onto the image sensor, where the laser speckle
pattern appears. The normalized blur (NB) obtained with this apparatus
is equivalent to a quantitative index of the blurring of a speckle
pattern and is an indicator of tissue blood velocity. The relative
change of the NB shows a strong correlation with the change in the ONH
tissue blood flow when measured by the hydrogen gas clearance method,
suggesting that the change of NB is indicative of the change in blood
flow.12
Rabbits were placed in holding boxes, and the
measurements described were obtained in animals under local anesthesia
with a drop of 0.4% oxybuprocaine hydrochloride (Benoxil; Santen,
Osaka, Japan).
For measurement of ONH blood velocity, the average NB over an area of 0.42 x 0.42 mm of the ONH free of surface vessels was measured in a randomly selected eye after mydriasis with a drop of 0.4% tropicamide (Mydrin M; Santen). It takes 0.18 seconds to record 98 scans and obtain one NB value. The NB at each time was calculated as the average of five successive measurements.
The IOP was measured using a calibrated pneumatonometer (Alcon, Tokyo, Japan) in the eye contralateral to that used for blood velocity measurement. One of the auricular arteries was cannulated with polyethylene tubes (SP28; Natume, Tokyo, Japan) in rabbits under local anesthesia with 2% lidocaine (Xylocaine spray; Fujisawa, Tokyo, Japan) for monitoring mean arterial blood pressure (BP). Mean arterial BP was calculated by [diastolic BP + 1/3(systolic BP - diastolic BP)].
Effect of NOS Inhibitor
After establishing the baseline values of NB, IOP, and BP, 1 ml
L-NAME (1, 10, or 100 mg/kg), D-NAME (10
mg/kg), or physiological saline was injected into an auricular vein
over 1 minute. Then the NB, IOP, and BP were measured every 15 minutes
for 2 hours. Six rabbits were tested with each dose of the drugs.
At 20 minutes after the injection of L-NAME (10 mg/kg), 1 ml L-arginine or D-arginine (both 10 mg/kg) was intravenously injected, and the NB was measured as above. For each type of arginine, six rabbits were used.
Effect of ACh
After establishing the baseline values of NB, IOP, and BP,
ACh (10 µg/kg per minute) or physiological saline was infused for 15
minutes into an auricular vein. In another group of rabbits, 1 ml
L-NAME (1 mg/kg) was injected intravenously 5 minutes
before the infusion of ACh. The NB, IOP, and BP were measured every 15
minutes for 90 minutes. Each group contained six rabbits.
Statistical Analysis
Data are expressed as the means ± SE. Statistical analysis
was performed by two-way analysis of variance (ANOVA) for repeated
measurements. If statistically significant difference was detected,
further assessment was performed by one-way ANOVA followed by
Dunnetts test. A difference was considered significant if
P < 0.05.
| Results |
|---|
|
|
|---|
The effects of L-NAME injection on the NB, IOP, and mean BP are shown in Figures 1 2 and 3 , respectively. Two-way ANOVA for repeated measurements showed significant differences between the control and L-NAME groups in each parameter. One-way ANOVA followed by Dunnetts test showed that L-NAME (10 and 100 mg/kg) significantly decreased the NB compared with that of the control group in a dose-dependent manner. In one-way ANOVA followed by Dunnetts test, L-NAME (100 mg/kg) also significantly increased the IOP at 45 and 60 minutes and the mean BP at 15 minutes compared with the control group, whereas there were no significant differences between the control and D-NAME (10 mg/kg) groups.
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
There have been previous reports on the effect of NOS inhibitors on the ONH circulation by Buerk et al.,6 Harino et al.,17 and Kondo et al.,7 but they used other methods to determine ONH blood flow (Buerk et al., Harino et al.: laser Doppler flowmetry, and Kondo et al.: microspheres). They also obtained results indicating that the vascular tone in the ONH was affected by NO, although their methods did not allow blood flow measurement over such a long time as in our study and could not be applied to conscious animals. In contrast, our method can directly detect changes under more physiological conditions and in more detail.
Systemic administration of L-NAME induced a dose-dependent and persistent decrease of the NB in the ONH, whereas D-NAME did not change it. Furthermore, the NB value recovered after the administration of L-arginine with L-NAME. These results indicate that the ONH circulation was reduced by competitive inhibition of NO synthesis. In other words, NO seems to be essential for maintaining basal ONH circulation. Mean BP and IOP increased only after injection of L-NAME at 100 mg/kg. The ocular perfusion pressure also increased significantly only at that dose at 15 minutes and was unchanged at other doses. ONH circulation was reduced although the ocular perfusion pressure was increased or unchanged after systemic administration of an NOS inhibitor, suggesting that NO played an important role in regulating the vascular resistance of the ONH.
The increase of the NB in the ONH during the infusion of ACh was inhibited by pretreatment with L-NAME. ACh appeared to increase the ONH circulation by promoting NO synthesis. Since the study by Furchgott and Zawadzki18 there have been various reports indicating that ACh dilates blood vessels by releasing NO. Our results confirm that this also occurred in the ONH circulation, at least in rabbits.
The present study suggests that NO regulates basal tissue circulation in the ONH and that ACh may increase the circulation by promoting NO synthesis in conscious rabbits.
| Acknowledgements |
|---|
| Footnotes |
|---|
Commercial relationships policy: N.
Corresponding author: Tetsuya Sugiyama, Department of Ophthalmology, Osaka Medical College, 2-7 Daigaku-cho, Takatsuki, Osaka 569-8686, Japan. opt017{at}poh.osaka-med.ac.jp
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. K. Petropoulos, J.-A. C. Pournaras, A. N. Stangos, and C. J. Pournaras Effect of Systemic Nitric Oxide Synthase Inhibition on Optic Disc Oxygen Partial Pressure in Normoxia and in Hypercapnia Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 378 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takayama, A. Tomidokoro, Y. Tamaki, and M. Araie Time Course of Changes in Optic Nerve Head Circulation after Acute Reduction in Intraocular Pressure Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1409 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Galassi, G Renieri, A Sodi, F Ucci, L Vannozzi, and E Masini Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma Br. J. Ophthalmol., June 1, 2004; 88(6): 757 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sato, T. Sakamoto, T. Nagaoka, F. Mori, K. Takakusaki, and A. Yoshida Role of Nitric Oxide in Regulation of Retinal Blood Flow during Hypercapnia in Cats Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4947 - 4953. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takayama, A. Tomidokoro, K. Ishii, Y. Tamaki, Y. Fukaya, T. Hosokawa, and M. Araie Time Course of the Change in Optic Nerve Head Circulation after an Acute Increase in Intraocular Pressure Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3977 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagaoka, T. Sakamoto, F. Mori, E. Sato, and A. Yoshida The Effect of Nitric Oxide on Retinal Blood Flow during Hypoxia in Cats Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3037 - 3044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okuno, H. Oku, T. Sugiyama, Y. Yang, and T. Ikeda Evidence that Nitric Oxide Is Involved in Autoregulation in Optic Nerve Head of Rabbits Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 784 - 789. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |